If you file a Risperdal lawsuit, there is guarantee that you will win a trial verdict or obtain a settlement. But based on previous cases, it appears that the makers of Risperdal may be motivated to settle claims in order to avoid revealing information that may lead to more lawsuits or avoid trial verdicts.
Aron Banks was the first person to take his Risperdal personal injury claim to trail against the drug manufacturer. Banks was prescribed Risperdal when he was nine years old even though the drug wasn’t approved for use by children at the time. He experienced rapid weight gain, suffered injury to his endocrine system and experienced psychological trauma. He also developed breasts large enough to require surgery to remove them, a condition known as Gynecomastia.
In September 2012, the makers of Risperdal decided agreed to settle Banks case under the condition that neither Banks nor his attorney would reveal the amount. But his attorney did tell the media that he believed “the possibility of more evidence of off-label marketing and improper conduct by Johnson & Johnson had something to do with the settlement.”